Introduction
Patient's medication records held on file by GPs and the list of drugs actually taken by the patients often differ [1] . Little is known about the specific reasons explaining these differences but possible reasons for discrepancies have been reported in the literature. These include a) patient errors in reporting their medication depending on drug type (tablet, syrup etc.) and prescription status [2] , b) physicians omitting to enquire about the consumption of OTC drugs [3, 4] , c) drugs being prescribed by other specialists. However, the extent to which these contribute to discrepancies is largely unknown.
The aim of our study was to analyze reasons for differences in the medication records held by GPs and the pattern of drugs actually consumed by their patients.
Methods and patients
This study was part of a cluster randomized trial on medication congruence. General practices (n = 17) consecutively recruited up to 16 patients. Inclusion criteria were: patients > 50 years of age taking > 4 drugs on a regular basis. Medication consumed by the patients was assessed by telephone interview. Physicians were asked to submit the current medication records of the patients held on file in their offices. All drugs were classified using the Anatomical Therapeutic Classification Code (ATC Code). Agreement was assumed when the subgroups (first 5 digits) were identical.
The list of drugs actually taken by the patient and obtained from an interview with the patients served as the reference -all omissions in the records provided by the GP were discussed in face-to-face interviews. The physician was confronted with the question: "Your patient stated that he/she is taking drug XY. Were you aware of this?" This was done in the case of each drug missing from the records held by the physician.
The physician was encouraged to review the patient's file for mitigating factors (i.e. referral letters, prescription information and personal notes). The possible reasons for the differences were divided into six categories and listed in hierarchical order (see Results section).
Data was collected and entered into an AC-CESS database (Microsoft Cooperation 2003) .
Ethical approval of the study was given by the local ethics committee.
Statistics: The study had an observational and hypothesis-generating purpose and therefore the analysis was descriptive.
Results
A total of 15 of the 17 GPs involved in recruiting the patients took part in an interview. A total of 87 of the 210 patients receiving polypharmacy and recruited in the study (Table 1) were taking at least one drug which was not included in the list of medications held in the records of the GP. Overall, the reasons for 170 omitted drugs were assessed. Possible reasons for these omissions, obtained from the interview with the GP were clustered into 6 categories (see below). -1. Documentation: The GP had spontaneous knowledge of a specific drug currently being taken by the patient but the drug was not listed in the medication records held by the GP. -2. Organization: The use of the drug had been documented in the patient history but was not listed in the current medication record provided by the GP. Therefore, although the doctor was not aware of its current use, information on the drug could be retrieved from a thorough review of the medication history held in the patient's file. The information about the drug was traceable through either a prescription issued by the practice, a letter of referral indicating prescription or recommendation by another specialist or in the form of personal notes. -3. OTC: The drug did not need a prescription or could not be prescribed and the GP had neither documented use of the drug nor did he or she know about its use by the patient. -4. Specialist: The prescription was issued by specialist/clinician. The treating GP knew that the patient was in the care of a consultant (referral issued) but had not received any written details of treatment. -5. Generic drugs: The patient was taking the same drug twice. This occurred because the drug was marketed under different trade names. In German pharmacies the substitution of drugs listed in a prescription is compulsory when 1) a cheaper drug with the same active pharmaceutical ingredient is available or 2) the patient's health insurance has a discount contract with a pharmaceutical company. -6. Other: Drug discrepancies that did not fall into the above listed categories.
We found that more than 90% of the differences observed above could be assigned to four of the explanatory categories. These were Documentation (21%), Organization (37%), OTC (21%) and Specialist (12%).
Overall, magnesium (A12CC) and platelet aggregation inhibitors (B01AC) were the drugs most often missing (17/170; 9/170) from the medication records held by GPs despite the fact that they were being consumed by the patient. Other frequent omissions included HMG CoA reductase inhibitors (6/170), proton pump inhibitor (5/170) and calcium (4/170) ( Table 2) .
Discussion
While many studies have confirmed the existence of the discrepancies described here [5, 6] , few studies have examined the underlying reasons in detail. To the best of our knowledge no previous study has assessed these reasons for the drug omissions using discussion with the GPs and simultaneously taking into account the information held on file regarding the patient's medication history. Barat et al. [6] examined the degree of disagreement between drug information on prescribed drugs collected from patients and that from their GPs. They did not assess underlying reasons but the authors suggested 2 factors: failure to update GP notes regularly, and prescription by specialists/outpatient clinics or hospitals. These assumptions could be confirmed by our results.
In a German study with a comparable patient population Harder et al. [7] found that 17% of patients received a prescription not found in the GP's documentation. The reasons were not assessed, but the authors suggested that the records were not updated frequently enough.
Green et al. [8] compared medication lists for patients with results from patient interviews conducted by pharmacists in a hospital-based acute medical care unit. They analyzed reasons for discrepancies relating to the level of care. Most of the discrepancies reported by these investigators were not examined in our study (namely drug dose, dose frequency, incomplete documentation of allergies). The lack of referral letters accounted for 3% of the discrepancies (12% in our study). This may have reflected the influence of a gatekeeper system without direct access to secondary care.
In a Danish study, Foss et al. [9] who compared the results of patient interviews and data from medical records, found that 4 -11% of discrepancies occurred because the same drug was packaged under two different names. Interestingly, this did not include cases of unintended double medication although Danish pharmacies, like those in Germany, are also required to substitute cheaper generic drugs to reduce costs.
We do not have any quantitative data on the extent of unintended double medication due to exchanging drugs in pharmacies, but Table 2 . Reasons for omissions (Category 1-6), percentage contribution to total omissions (n = 170) and the ATC classification of the drugs involved (ATC Code is only listed for those drugs found more than once.).
Category
Number of drugs (n = 170) ATC Classification of omitted drugs
Documentation 35 (21%)
A12CC Magnesium (n = 5) M01AE Propionic acid derivates (n = 2) 2. Organization 63 (37%) A02BC Proton pump inhibitors (n = 2) A10BA Biguanides (n = 2) B01AC Platelet aggregation inhibitors (n = 7) B03AA Bivalent iron preparations (n = 2) C03AA Thiazides (n = 2) C09AA ACE inhibitors (n = 2) C10AA HMG CoA reductase inhibitors (n = 5) G04CA Alpha adrenoreceptor antagonists (n = 3) L04AA Selective immunosuppressants (n = 2) N02AX Other opioids(n = 2) N02BB Pyrazolones (n = 2) N06DP Other antidementiva drugs(n = 2) R03AK Adrenergics for obstructive airway disease (n = 3) 3. OTC 36 (21%) A12AA Calcium (n = 4) A12CC Magnesium (n = 11) C05CP Other capillary stabilizing agents (n = 2) N06DP Other antidementiva drugs (n = 2) S01XC Other ophthalmological agents (n = 3) V06 General nutrients (n = 5) 4. Specialist 20 (12%) N06AA Non-selective monoamine reuptake inhibitors (n = 2) S01ED Beta-blocking agents (n = 2) 5. Generic drug 5 (3%) A10BA Biguanides (n = 2) C09AA ACE inhibitors (n = 2) 6. Other 11(6%) A02BC Proton pump inhibitors (n = 2) C03AA Thiazides (n = 2) C03CA Sulfonamides (n = 2) data from case reports, questionnaires and qualitative studies [10] indicate that this is a clinically important source of error. The question used to assess the reasons for discrepancies "Your patient is taking drug XY. Were you aware of this?" can be seen as both a strength and as a weakness of this study. Although the open and collegial atmosphere in the interviews allowed this question to be asked in a non-accusing manner, it was not always possible to be 100% sure that the information provided by the GP was accurate when confirming knowledge about a specific drug used by the patient.
Furthermore, our focus was on the omissions in the medication records held by the GP. It was not possible to assess adherence or dose-related discrepancies. The discrepancies we found were partly influenced by the health care system and thus our results are only partly applicable to other countries. In the German healthcare system, the GP does not usually operate as a "gate-keeper" and there is no central database for prescribed drugs. This means that direct access to secondary care is possible for patients and makes communication between specialists and GPs all the more important. Nevertheless, discrepancies due to a lack of information from specialist treatment are also known in other health care systems. It seems that the most reliable source for the patient's active medication is a personal electronic medication profile [11] though this still has shortcomings with regard to OTC drugs. Overcoming these difficulties will be important for improving patient safety. The first and most important step would be to improve the process of documentation within the practice.
Conclusion
Several reasons which explain differences between current medication records held on file by GPs and the list of the drugs actually consumed by the patient have been identified. These differences do not necessarily reflect lack of knowledge about the drug taking habits of the patient per se. However, it is likely that improving communication, i.e., between clinicians and with patients, and improving organizational aspects within practices will reduce the majority of the discrepancies reported here.
